Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia
Status:
Withdrawn
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The COVID-19 pandemic has been spreading continuously, and in Brazil, until July 19, 2020,
there have been more than 2,000,000 cases with more than 79,000 deaths, with daily increases.
The present study proposes to evaluate the efficacy of methylprednisolone and heparin in
treatment of patients with COVID-19 pneumonia in a randomized, controlled, 2x2 factorial
study.